Conversely, TRPV4 was down-regulated in prostate adenocarcinoma-derived endothelial cells (A-TECs), which displayed enhanced motility due to their lower mechanosensitivity toward extracellular matrix (ECM) stiffness. This evidence concerns the gene TRPV4 and prostate adenocarcinoma.